Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.82 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.67 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.61 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.60 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.55 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15846850 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL526043 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL543273 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL9830302 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL18038484 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL543291 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL19049827 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL9830306 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL17204092 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL10829302 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104263248-A | Weakly acidic copper polishing solution applicable to low downforce | SHENZHEN LEAGUER MATERIAL CO LTD | 2015-01-07 | — | — | CN | claimed |
| EP-1393518-B1 | ARYLSULFATASE-INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS | HENKEL AG & CO KGAA (DE) | 2010-03-17 | — | — | EP | claimed |
| US-5238917-A | Drug delivery, storage stability | TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) | 1993-08-24 | — | — | US | claimed |
| EP-0418642-B1 | HIGH-ABSORBABLE TRANSVAGINAL PREPARATION CONTAINING BIOLOGICALLY ACTIVE PEPTIDES | TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) | 1993-06-09 | — | — | EP | claimed |
| EP-0418642-A1 | High-absorbable transvaginal preparation containing biologically active peptides | TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) | 1991-03-27 | — | — | EP | claimed |
| JP-4243809-A | — | — | None | — | — | JP | disclosed |
| CN-117414304-A | Composition easy to form liquid crystal and application thereof in personal washing and caring products | 如薇化妆品有限公司 | 2024-01-19 | — | — | CN | disclosed |
| US-11559071-B2 | N-acyl-amino acid derivatives for improvement of the flavour profile of edible compositions | GIVAUDAN SA (CH) | 2023-01-24 | — | — | US | disclosed |
| US-11524933-B2 | In or relating to organic compounds | GIVAUDAN SA (CH) | 2022-12-13 | — | — | US | disclosed |
| US-20220133857-A1 | ORAL FORMULATION AND TREATMENT OF PTH ANALOG | ANYA BIOPHARM INC. (TW) | 2022-05-05 | — | — | US | disclosed |
| US-11246823-B2 | Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules | L'OREAL (FR) | 2022-02-15 | — | — | US | disclosed |
| EP-3883595-A1 | N-ACYLATED FATTY AMINO ACIDS TO REDUCE ABSORPTION VARIABILITY IN CANNABINOID BASED COMPOSITIONS | Receptor Holdings, Inc. (US) | 2021-09-29 | — | — | EP | disclosed |
| WO-1998004257-A1 | PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | UNIVERSITY OF PITTSBURGH (US) | 1998-02-05 | — | — | WO | disclosed |
| US-5700821-A | INHIBIT CELL PROLIFERATION | UNIVERSITY OF PITTSBURGH (US) | 1997-12-23 | — | — | US | disclosed |
| EP-0572167-B1 | Cosmetic composition | UNILEVER PLC (GB) | 1996-10-09 | — | — | EP | disclosed |
| EP-0572167-A1 | Cosmestic composition | UNILEVER PLC (GB) | 1993-12-01 | — | — | EP | disclosed |
| US-5238917-A | Drug delivery, storage stability | TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) | 1993-08-24 | — | — | US | disclosed |
| EP-0418642-B1 | HIGH-ABSORBABLE TRANSVAGINAL PREPARATION CONTAINING BIOLOGICALLY ACTIVE PEPTIDES | TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) | 1993-06-09 | — | — | EP | disclosed |
| JP-H04243809-A | CLEANING AGENT COMPOSITION HAVING LOW IRRITATION | KANEBO LTD | 1992-08-31 | — | — | JP | disclosed |
| EP-0418642-A1 | High-absorbable transvaginal preparation containing biologically active peptides | TEIKOKU SEIYAKU KABUSHIKI KAISHA (JP) | 1991-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11246823-B2 | Molecularly imprinted polymer of sol-gel type for selectively trapping odorous molecules | TAS2R30, TAS1R1, TAS2R10 | NOD1 4516/4885PLA2G2C 2147/4885PLA2G10 1999/4885 |
| US-11524933-B2 | In or relating to organic compounds | GABRB3, GABRB1, GABRB2 | NOD1 2489/4885PLA2G2C 3900/4885PLA2G10 4262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.